# MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
Canonical URL: https://biopharmsignal.com/news/MDXG/mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29
Ticker: MDXG
Company: MiMedx
Source: MiMedx
Published: 2026-04-22 12:00 EST
Original Source URL: https://mimedx.gcs-web.com
## Summary

MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, April 29, 2026.

## Article Body
MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, April 29, 2026.
## Recent Company News
- 2026-07-20 12:00 EST — [MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29](https://biopharmsignal.com/news/MDXG/mimedx-to-host-second-quarter-2026-operating-and-financial-results-conference-ca-b62fe7a7) — Source: MiMedx
- 2026-05-21 12:45 EST — [MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference](https://biopharmsignal.com/news/MDXG/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference) — Source: MiMedx
- 2026-05-08 12:00 EST — [MIMEDX Announces Launch of G4Derm® Plus](https://biopharmsignal.com/news/MDXG/mimedx-announces-launch-of-g4dermr-plus) — Source: MiMedx
- 2026-04-29 20:01 EST — [MIMEDX Announces First Quarter 2026 Operating & Financial Results](https://biopharmsignal.com/news/MDXG/mimedx-announces-first-quarter-2026-operating-and-financial-results) — Source: MiMedx
- 2026-04-22 12:00 EST — [MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29](https://biopharmsignal.com/news/MDXG/mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29) — Source: MiMedx
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)